Silicon Valley Community Foundation’s Royalty Pharma RPRX Stock Holding History

Silicon Valley Community Foundation’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-33,090	Closed	-$936K	–	19
2024 Q3	$936K	Sell	33,090 -46,454	-58%	-$1.29M	0.04%	15
2024 Q2	$2.1M	Sell	79,544 -46,454	-37%	-$1.29M	0.09%	12
2024 Q1	$3.83M	Sell	125,998 -46,454	-27%	-$1.37M	0.14%	12
2023 Q4	$4.84M	Sell	172,452 -185,818	-52%	-$5.11M	0.5%	9
2023 Q3	$9.72M	Sell	358,270 -16,366,995	-98%	-$486M	1.18%	7
2023 Q2	$544K	Buy	16,725,265 +15,692,945	+1,520%	+$532M	0.07%	14
2023 Q1	$37.2M	Hold	1,032,320	–	–	5.36%	6
2022 Q4	$40.8M	Buy	+1,032,320	New	+$43.1M	7.84%	5

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Silicon Valley Community Foundation's RPRX Position: Q4 2024 in Review

Silicon Valley Community Foundation sold out of Royalty Pharma (RPRX) in Q4 2024, closing a stake of 33,090 shares — an estimated $936K sold.

Silicon Valley Community Foundation first reported a position in RPRX in Q4 2022 and held it in 8 quarters. The position peaked at $40.8M in Q4 2022. 416 funds tracked by Wall St. Rank hold RPRX as of Q4 2024.

Silicon Valley Community Foundation reported no remaining Royalty Pharma position as of Q4 2024 after selling out during the quarter.
Silicon Valley Community Foundation sold 33,090 Royalty Pharma shares in Q4 2024, an estimated $936K.
Silicon Valley Community Foundation first reported a position in Royalty Pharma in Q4 2022 and held it in 8 quarters.
Silicon Valley Community Foundation's Royalty Pharma position peaked at $40.8M in Q4 2022.
416 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2024.

Based on Silicon Valley Community Foundation's 13F filing for Q4 2024, filed 18 Feb 2025.